IP Group

IP Group is a venture capital investment firm established in 2001 and headquartered in London, United Kingdom. The company's primary focus is on the commercialization of intellectual property developed by research-intensive institutions, leveraging its expertise to create value for shareholders and partners. IP Group specializes in identifying and nurturing promising intellectual property, facilitating the development of businesses, and forming strategic commercial partnerships. With a strong background in both industry and finance, the firm has built a solid track record of delivering consistent results across various sectors, including clean technology, life sciences, and deep technology.

Aubrey F.C.A., FCA, Alan John

CEO

Dani Bach

Partner, Life Sciences

Manjari Chandran-Ramesh

Investment Director

Michael Molinari

Managing Director, IP Group Australia

Ben Murphey

Investment Director

Greg Smith

CEO and Board Member

Lee Thornton

Partner, Technology

Wilson, Ian

Investment Manager

Moray Wright

CEO, Parkwalk Advisors

Past deals in Europe

AccelerComm

Series B in 2023
AccelerComm is an exciting semiconductor IP-core company that provides solutions to accelerate the next generations of wireless communications (3GPP rel 14, rel 15 and beyond). Their technology solves the bottleneck that would otherwise limit the speed of next generation wireless communication, namely the error correction decoding that is required to overcome the effects of noise, interference and poor signal strength.
Intrinsic Semiconductor Technologies is established to developed silicon-oxide based RRAM technologies. Intrinsic's technology is fully air stable and inherently CMOS compatible. Intrinsic's core technology can be configured as non-volatile memory, multilevel memory, hardware acceleration for Machine Learning, and neuromorphic devices.

Nexeon

Series D in 2022
Nexeon is a leading international developer and manufacturer of breakthrough silicon-based anode materials for rechargeable lithium-ion batteries. These are fundamental to the achievement of ‘net zero’ and a sustainable environment. Nexeon’s battery materials enable significantly higher cell energy density, allowing the design of lighter, smaller and more cost effective batteries. In turn, this leads to enhanced performance for an increasing range of diverse consumer and commercial markets, including electric vehicles, where range and charging times can beneficially be impacted. Nexeon is based in Oxfordshire with operations in Japan. It has a well-established multi-disciplinary technical team with a wide range of expertise. For more details, please visit https://www.nexeon.co.uk

Abliva

Post in 2022
Abliva AB is a biotechnology company based in Lund, Sweden, that specializes in the research and development of mitochondrial medicine. The company is advancing several drug candidates, including KL1333, which is in Phase I clinical trials for chronic treatment of primary mitochondrial diseases, and NV354, which is being prepared for clinical trials targeting Complex I deficiency in mitochondrial diseases. Additionally, Abliva is developing NeuroSTAT for the treatment of traumatic brain injuries and is currently engaged in a Phase II/III adaptive clinical study for this indication. The company also has a cyclophilin-D-inhibiting cyclosporine, CicloMulsion®, undergoing a Phase III clinical study for reperfusion injury. Abliva collaborates with various institutions and organizations, including academic hospitals and pharmaceutical companies, to enhance its research and development efforts. Founded in 2000 and previously known as NeuroVive Pharmaceutical AB, the company rebranded to Abliva AB in May 2020.

MoA Technology

Series B in 2022
MoA Technology Limited is a plant genetics company spun out from the University of Oxford. Professor Liam Dolan, FRS, has developed an innovative approach for the discovery of agricultural technologies that will enable farmers to produce healthy food from sustainable crop systems.

SLAMcore

Series A in 2022
Slamcore Limited specializes in developing simultaneous localization and mapping (SLAM) solutions for applications in augmented and virtual reality, robotics, and autonomous vehicles. Founded in 2016 and based in London, the company focuses on making commercial-grade spatial intelligence accessible. Its advanced SLAM software enables robots and drones to effectively navigate and comprehend their environment, utilizing methods such as Visual SLAM, sensor fusion, and Event Camera SLAM. These technologies allow for real-time processing and integration of data from various sensors, enhancing capabilities in areas like motion estimation and panorama reconstruction. Slamcore collaborates with partners to optimize the interplay between software and hardware, ensuring a balanced approach to performance and cost-effectiveness. By providing robust SLAM algorithms, the company aims to transform spatial AI into practical solutions for various industries, ultimately facilitating the integration of robots into everyday life.

Gripable

Series A in 2022
Gripable develops digital therapy tools, combining them with mobile games, and motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering from impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of the hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.

Kynos Therapeutics

Seed Round in 2022
Kynos Therapeutics is a biotechnology company focused on developing KMO inhibitors to address unmet medical needs in inflammation, immunity, and metabolism. The company aims to block the action of the enzyme KMO, which plays a crucial role in regulating systemic inflammation and is implicated in various medical conditions. By providing new therapies that target this key enzyme, Kynos Therapeutics seeks to offer innovative treatments for conditions where there is a significant demand for effective medicines.

Vytal

Series A in 2022
Vytal is a provider of software-enabled reusable packaging solutions to eliminate single-use packaging waste in the food and beverage industry. It offers a reusable container system and container management software to facilitate sustainable takeaway and delivery services, serving restaurants, supermarkets, caterers, canteens, and event organizers.

Helio Display Materials

Series A in 2022
Helio develops materials for a new generation of brighter, more colorful displays. Helio's materials can display richer, less filtered colors, resulting in a better overall visual experience while using significantly less power. Helio is on a mission to improve display performance and efficiency through the use of perovskite science. In order to speed up sound research and development, they collaborate with the scientific and business minds in their industry.

Barocal

Seed Round in 2022
Barocal specializes in innovative cooling technology aimed at addressing low-carbon refrigeration needs. The company has developed a system that utilizes materials capable of significant thermal changes when pressure is applied or removed. This unique approach enhances energy efficiency while ensuring a zero greenhouse warming impact, particularly in the commercial food and drink refrigeration sector. By implementing Barocal's technology, clients can effectively reduce their indirect emissions of greenhouse gases, contributing to a more sustainable environment.

First Light Fusion

Series C in 2022
First Light Fusion was spun out from the University of Oxford and focuses on researching energy generation by inertial confinement fusion. Its platform explores a number of alternative research directions that harness fundamental physics focusing on power generation and theoretical analysis, detailed numerical simulation, and experimental validation that helps clients to discover a new source of energy. The company directly employs a team of engineers and physicists and collaborates closely with a number of academic organizations, including the University of Oxford, Warwick University, UCL, and Imperial College, London. The company was founded by Professor Yiannis Ventikos and Dr. Nicholas Hawker and is based in Yarnton, Oxfordshire.

Bramble Energy

Series B in 2022
Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.

Microbiotica

Series B in 2022
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and in vivo models.

Diffblue

Seed Round in 2022
Diffblue is a developer of automated testing software that enhances Java development by automatically generating unit tests. The company is a spin-out of the AI research group at Oxford, its automated code-writing capability has far-reaching potential and will eventually transform how software is written. Initially, Diffblue’s technology was deployed to save developers time and ensure robustness in one of software development's most tedious and time-consuming areas: writing unit tests. Diffblue's product stands out from code suggestion tools in that it works completely autonomously, using reinforcement learning to write fully formed tests that are guaranteed to compile, run, and find bugs.

Navenio

Venture Round in 2021
Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

ieso

Series B in 2021
Ieso Digital Health Ltd. specializes in providing online evidence-based cognitive behavioral therapy (CBT) to individuals facing various mental health challenges, including anxiety and depression. The company's unique online service facilitates real-time communication between accredited therapists and patients through a secure virtual environment, where sessions are conducted via text. This approach not only mirrors traditional face-to-face interactions but also offers greater convenience for users. Ieso began its operations in the UK in 2000 and has since expanded into the US market, collaborating with Medicaid and commercial health plans to enhance access to mental health services. The company’s therapy model has demonstrated effectiveness, requiring fewer sessions to achieve recovery and showing improved outcomes compared to conventional therapy methods. Ieso serves a diverse clientele, including health providers, private individuals, and businesses, and is recognized for its rapid growth in the digital health sector.

Teya

Series C in 2021
Teya is an all-in-one solution for small and growing businesses. From payments, to loyalty, to the cash advance merchants use to give their shops that facelift – Teya has helped over 300,000 business owners to connect with the joy of running their business.

Hinge Health

Series E in 2021
One in two people experience debilitating back, neck, shoulder, or joint pain — but traditional treatments have failed to meet their needs. Physical therapy can be expensive and hard to access; appointments often involve long commutes and missed work. Making matters worse, unresolved pain can trigger the overuse of opioids and surgeries. We’re making high-quality care accessible by pairing wearable sensors and computer vision with a world-class clinical team. Hinge Health puts a digital clinic in every member's pocket. Now millions of people can access personalized digital care from a physical therapist, guidance on behavior change from a health coach, and expert consultations with an orthopedic surgeon. With a single app and wearable technology like our Enso device, we’re helping empower people to move beyond pain.

Monolith AI

Series A in 2021
Monolith AI is a software company that uses machine learning and data science to help engineers improve the product development process. It enables companies to monetize on their old simulation and test data by using it to anticipate the behavior of new products. Companies can optimize their R&D process by reducing the number of simulations, tests, and prototypes required to develop a new product delivering faster and better products. The company was founded in 2016 and is headquartered in London, England.

Arkivum

Private Equity Round in 2021
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally. We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.

Pulmocide

Series C in 2021
Pulmocide Ltd, a company focused on the discovery and development of a new generation of inhaled medicines for the treatment of serious viral and fungal infections of the respiratory tract.

Oxford Nanopore Technologies

Venture Round in 2021
Oxford Nanopore Technologies is a biotechnology company that develops and commercializes nanopore sequencing technology. Their novel, electronics-based DNA/RNA sequencing technology is being used in more than 80 countries, for a range of biological research applications. These include large scale human genomics, cancer research, microbiology, plant science, and environmental research. Nanopore sequencing is also being explored beyond research, where it has the potential to provide rapid, meaningful information in the fields of healthcare, agriculture, food and water surveillance, and education. Oxford Nanopore’s proprietary technology is fully scalable for any requirement. Small formats such as Flongle address the need for on-demand, rapid, smaller tests or experiments, and can be used in labs or in the field. The pocket-sized MinION is a powerful and portable sequencing device that can deliver high volumes of long-read sequence data. The benchtop GridION X5 can run up to five MinION Flow Cells at a time, on-demand, for larger genomics projects. The recently launched PromethION is the largest format for nanopore sequencing, designed to offer on-demand use of up to 48 Flow Cells – each of which can offer more than 100Gb of sequencing data. Focusing on ease of use, nanopore sequencing offers easy and rapid preparation, including a ten-minute library preparation kit and the automated, programmable VolTRAX. Supported by a broad patent portfolio, the Oxford Nanopore pipeline includes multiple generations of nanopore-based sensing technologies, including those based on both biological and solid-state nanopores.
Intrinsic Semiconductor Technologies is established to developed silicon-oxide based RRAM technologies. Intrinsic's technology is fully air stable and inherently CMOS compatible. Intrinsic's core technology can be configured as non-volatile memory, multilevel memory, hardware acceleration for Machine Learning, and neuromorphic devices.

Oxular

Venture Round in 2021
Oxular is a clinical-stage retinal therapeutics company that is developing technology to transform the treatment of retinal disease, offering patients life-changing solutions to their unmet needs.

C-Capture

Venture Round in 2021
C-Capture Limited, founded in 2008 and based in Leeds, United Kingdom, specializes in the development and design of solvent systems for the removal of carbon dioxide (CO2) from gas streams. The company utilizes its expertise in CO2-based chemistry and engineering to create absorbents for reversible CO2 capture, particularly in post-combustion processes. C-Capture focuses on providing non-toxic and economically viable carbon capture solutions for emission sources, including flue gases from power generators and hard-to-abate industries. By offering innovative technology for capturing CO2, C-Capture aims to contribute to more sustainable electricity generation and address the environmental challenges posed by greenhouse gas emissions.

Oxa

Series B in 2021
Oxbotica develops autonomous vehicle software. They provide autonomy software that has low compute power requirements. They use laser vision and radar for localization, redundancy, and cloud management services that enable businesses to help bring autonomy to vehicles.

AudioScenic

Series A in 2020
AudioScenic is changing the way we experience audio. Using small arrays of speakers and advanced head tracking technologies, immersive 3D Sound will no longer require headphones or speakers located all around a room. We will deliver an unrivalled, authentic and natural audio experience for consumers of immersive Gaming, VR and Movie audio. The AudioScenic system allows a user to experience sounds in a way which is far superior to a conventional loudspeaker system. In a traditional loudspeaker set-up, sound radiates out from the speaker before bouncing off the walls and other objects in the room prior to reaching the ear. What you hear is a mix of the original and reflected sound creating, at best, a distorted "3D" effect. In contrast, AudioScenic delivers controlled and independent sound beams direct to the left and right ears. In this way we can create "virtual headphones" and deliver spatial audio which simulates sounds positioned in 3D space all around the listener. In addition, our proprietary head tracking technology enables the independent beams of sound to follow the ears of a listener, delivering perfect 3D Sound no matter what position they occupy or whether they move either whilst playing a computer game or watching a movie. Thanks to AudioScenic's technology the "sweet-spot" concept belongs to the past. AudioScenic offers solutions for a range of different platforms and a variety of market applications. Our designs use expandable loudspeakers arrays with varying numbers of drivers to create precisely controlled sound beams. AudioScenic works hand-in-hand with our partners and customers to provide the detailed acoustic design support required to implement different products including Home Cinema, Gaming, Simulation, VR and public space audio systems. The AudioScenic Virtua 3D Engine has been ported to leading signal processing platforms. The Virtua Engine uses our patented ultra-efficient signal processing architecture to allow implementation across a range of cost effective systems. AudioScenic provides optimized implementations of our Virtua Engine and our image processing technology to partners and customers.

AccelerComm

Series A in 2020
AccelerComm is an exciting semiconductor IP-core company that provides solutions to accelerate the next generations of wireless communications (3GPP rel 14, rel 15 and beyond). Their technology solves the bottleneck that would otherwise limit the speed of next generation wireless communication, namely the error correction decoding that is required to overcome the effects of noise, interference and poor signal strength.

Bramble Energy

Series A in 2020
Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.

MISSION Therapeutics

Venture Round in 2020
MISSION Therapeutics is a biotechnology company specializing in developing drugs that target the cellular process of deubiquitylation for the treatment of cancer and other diseases. Their focus is on developing small molecule drugs that selectively inhibit specific deubiquitylating enzymes (DUBs), which play crucial roles in regulating protein degradation and cellular processes. These drugs aim to intervene in disease mechanisms where DUB dysregulation is implicated, offering potential therapeutic benefits.

Oxford Ionics

Seed Round in 2020
Oxford Ionics is a quantum computing startup that provides innovations for the development of accurate and dependable quantum computers by combining high-performance qubits - trapped ions - with a noiseless electronic qubit control technology. Oxford Ionics' technology enables the manipulation of qubits with negligible noise and reliability, giving clients access to quantum computers that can control interconnected qubit registers in parallel and without sacrificing performance.

Ibex Innovations

Venture Round in 2020
IBEX Innovations Limited specializes in developing and commercializing advanced X-ray detector technology that provides high sensitivity materials information using standard X-ray systems. Founded in 2010 by Dr. Gary Gibson and based in Sedgefield, United Kingdom, the company has created the IBEX multi absorption plate (MAP) technology, which enhances traditional detectors by integrating materials information while maintaining key performance characteristics like speed and spatial resolution. IBEX's solutions are utilized across various sectors, including healthcare for bone mineral density assessment, electronics inspection, food safety, and security applications. The company collaborates with academic institutions, such as the Mathematics Department at Durham University, and maintains partnerships with healthcare organizations to validate its technology in medical imaging. Supported by venture capital and grants, IBEX Innovations continues to advance its technology to transform standard X-ray imaging into powerful diagnostic tools.

Navenio

Series A in 2020
Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

Quantum Motion

Series A in 2020
Quantum Motion Technologies is building a universal quantum computer in Silicon, using CMOS compatible processes.

RFC Power

Seed Round in 2020
RFC Power is a developer of flow battery systems. RFC Power are developing new classes of low-cost redox flow battery chemistry, leveraging concepts from fuel cells.

Mixergy

Series A in 2019
Mixergy Ltd. offer a cost-effective solution to save energy and facilitate more renewable power generation through grid balancing. Mixergy tanks achieve better utilisation of solar PV and heat pumps.

Inflowmatix

Series B in 2019
Inflowmatix is a spin-out company from the InfraSense Labs at the Department of Civil and Environmental Engineering of Imperial College London. Inflowmatix builds upon the unique cross-disciplinary expertise from sensing to advanced modelling and optimization and the active research collaborations with water utilities and IT system integrators. Inflowmatix creates innovative and customer tailored solutions for the steady-state, resilient and energy efficient operation of water supply networks by continuously monitoring and analyzing the fluid dynamics in complex networks. This allows operators to continuously gain unique insight and proactively optimize the dynamic network performance in order to extend the service life of infrastructure assets. Our expertise in modelling the steady and unsteady-state hydraulics of water distribution networks, combined with knowledge and experience in the design and implementation of embedded electronic systems, yield compelling returns on investment for our customers. Many cities in the world face the problem of ageing infrastructure, increasing population demand and climate change. This combined with increasing regulatory and financial pressure means water utilities are actively seeking novel, integrated and optimized operational strategies for managing leakage, demand and energy efficiency in order to deliver high-quality of service to customers within cost constraints. Water companies and operators are facing unparalleled challenges to meet increasing demand with limited water and financial resources. By successfully applying the technologies and analytics developed by Inflowmatix to water supply networks, we significantly improve the management of leakage, demand, energy and operational incidents, thus providing multiple operational benefits for network operators.

Growave.ag

Seed Round in 2019
Growave is an Agtech startup company offering herbicide free weed management.

WaveOptics

Series C in 2019
WaveOptics is a designer and manufacturer of diffractive waveguides for wearable Augmented Reality (AR) devices. The company aims to be the key optical component in wearable augmented reality devices. WaveOptics was founded in 2014 and is headquartered in Abingdon, Oxfordshire.

SAM Labs

Series A in 2019
SAM Labs provides everything you need to deliver the most engaging STEAM learning experience to your classroom. It seamlessly connects software and hardware with lesson plans that cover a wide variety of subjects, making learning about coding accessible, experimental, interactive and fun. SAM Labs kits are bursting with wireless electronic blocks that each have a personality of their own. From lights to motors to sliders to buzzers, every Bluetooth-enabled block can connect to the others via the app to do something different. Press a button to turn a light on! Use a light sensor to activate an alarm! With the app, students can code the behaviours of blocks in any way they can imagine, enabling them to make anything from simple reactions to complex creations in minutes. Students can use SAM Labs to design, write and debug programs, applying sequencing, selection and iteration. They will use logical reasoning to write algorithms, incorporating variables, inputs and outputs. Using the blocks and app, they will learn to control and simulate physical systems.

Azuri Technologies

Corporate Round in 2019
Azuri Technologies Ltd. specializes in the development, manufacturing, and installation of solar power products aimed at off-grid communities, primarily in Africa and the United Kingdom. Founded in 2012 and headquartered in Cambridge, the company provides a variety of solar solutions, including AzuriTV, a solar-powered television, and various solar home systems that offer lighting, mobile phone charging, and other essential services. Its PayGo system allows users to access solar energy through a pay-as-you-go model, making clean energy affordable and accessible without the need for government subsidies. Azuri Technologies has established distribution networks in countries such as Kenya, Uganda, South Sudan, Zambia, and South Africa, addressing the energy access challenges faced by 1.3 billion people globally. By leveraging mobile technology, Azuri transforms energy access into a viable business, offering families a cost-effective alternative to traditional kerosene use.

Ibex Innovations

Venture Round in 2019
IBEX Innovations Limited specializes in developing and commercializing advanced X-ray detector technology that provides high sensitivity materials information using standard X-ray systems. Founded in 2010 by Dr. Gary Gibson and based in Sedgefield, United Kingdom, the company has created the IBEX multi absorption plate (MAP) technology, which enhances traditional detectors by integrating materials information while maintaining key performance characteristics like speed and spatial resolution. IBEX's solutions are utilized across various sectors, including healthcare for bone mineral density assessment, electronics inspection, food safety, and security applications. The company collaborates with academic institutions, such as the Mathematics Department at Durham University, and maintains partnerships with healthcare organizations to validate its technology in medical imaging. Supported by venture capital and grants, IBEX Innovations continues to advance its technology to transform standard X-ray imaging into powerful diagnostic tools.

STORM Therapeutics

Series A in 2019
Targeting pathways that modify RNA to deliver novel cancer therapeutics.

Aqdot

Series B in 2019
Aqdot‘s technology allows for an energy- and raw material-efficient way of manufacturing microcapsules, leading to lower energy consumption and less waste. Potential applications include encapsulating enzymes in laundry detergents, or encapsulating fertilisers in the agrochemical sector. Microencapsulation is a multi-billion-per-annum industry with established applications in household and personal care, food and agrochemical markets.

AccelerComm

Seed Round in 2019
AccelerComm is an exciting semiconductor IP-core company that provides solutions to accelerate the next generations of wireless communications (3GPP rel 14, rel 15 and beyond). Their technology solves the bottleneck that would otherwise limit the speed of next generation wireless communication, namely the error correction decoding that is required to overcome the effects of noise, interference and poor signal strength.

C-Capture

Venture Round in 2019
C-Capture Limited, founded in 2008 and based in Leeds, United Kingdom, specializes in the development and design of solvent systems for the removal of carbon dioxide (CO2) from gas streams. The company utilizes its expertise in CO2-based chemistry and engineering to create absorbents for reversible CO2 capture, particularly in post-combustion processes. C-Capture focuses on providing non-toxic and economically viable carbon capture solutions for emission sources, including flue gases from power generators and hard-to-abate industries. By offering innovative technology for capturing CO2, C-Capture aims to contribute to more sustainable electricity generation and address the environmental challenges posed by greenhouse gas emissions.

Featurespace

Venture Round in 2019
Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countries to prevent fraud and financial crime. ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.

AudioScenic

Seed Round in 2019
AudioScenic is changing the way we experience audio. Using small arrays of speakers and advanced head tracking technologies, immersive 3D Sound will no longer require headphones or speakers located all around a room. We will deliver an unrivalled, authentic and natural audio experience for consumers of immersive Gaming, VR and Movie audio. The AudioScenic system allows a user to experience sounds in a way which is far superior to a conventional loudspeaker system. In a traditional loudspeaker set-up, sound radiates out from the speaker before bouncing off the walls and other objects in the room prior to reaching the ear. What you hear is a mix of the original and reflected sound creating, at best, a distorted "3D" effect. In contrast, AudioScenic delivers controlled and independent sound beams direct to the left and right ears. In this way we can create "virtual headphones" and deliver spatial audio which simulates sounds positioned in 3D space all around the listener. In addition, our proprietary head tracking technology enables the independent beams of sound to follow the ears of a listener, delivering perfect 3D Sound no matter what position they occupy or whether they move either whilst playing a computer game or watching a movie. Thanks to AudioScenic's technology the "sweet-spot" concept belongs to the past. AudioScenic offers solutions for a range of different platforms and a variety of market applications. Our designs use expandable loudspeakers arrays with varying numbers of drivers to create precisely controlled sound beams. AudioScenic works hand-in-hand with our partners and customers to provide the detailed acoustic design support required to implement different products including Home Cinema, Gaming, Simulation, VR and public space audio systems. The AudioScenic Virtua 3D Engine has been ported to leading signal processing platforms. The Virtua Engine uses our patented ultra-efficient signal processing architecture to allow implementation across a range of cost effective systems. AudioScenic provides optimized implementations of our Virtua Engine and our image processing technology to partners and customers.

import.io

Series B in 2018
Import.io is the number one Web Data Integration provider. Import.io deliver the world’s data directly to enterprises, fueling business insight and competitive advantage. The Import.io Web Data Integration solution extracts, prepares and integrates high-quality comprehensive web data into customers’ analytics platforms and business applications. The company delivers data to more than 850 customers from millions of web sources.

WaveOptics

Series C in 2018
WaveOptics is a designer and manufacturer of diffractive waveguides for wearable Augmented Reality (AR) devices. The company aims to be the key optical component in wearable augmented reality devices. WaveOptics was founded in 2014 and is headquartered in Abingdon, Oxfordshire.

Genomics

Series B in 2018
Genomics plc aiming to lead the genomic transformation of healthcare, to develop and apply sophisticated analyses of massive integrated genomic and phenotypic datasets to learn about human biology and reveal the human wiring diagram They will lead the way through this challenge, using their expertise and experience to unleash the potential of genomics and set the standards by which organisations and patients can benefit from genomic data.

Ultraleap

Series C in 2018
Ultraleap is the world leader in mid-air haptics and 3D hand tracking. The company's breakthrough haptic technology (previously Ultrahaptics) uses ultrasound to create rich, three-dimensional shapes and textures that can be felt, but not seen.

Ibex Innovations

Venture Round in 2018
IBEX Innovations Limited specializes in developing and commercializing advanced X-ray detector technology that provides high sensitivity materials information using standard X-ray systems. Founded in 2010 by Dr. Gary Gibson and based in Sedgefield, United Kingdom, the company has created the IBEX multi absorption plate (MAP) technology, which enhances traditional detectors by integrating materials information while maintaining key performance characteristics like speed and spatial resolution. IBEX's solutions are utilized across various sectors, including healthcare for bone mineral density assessment, electronics inspection, food safety, and security applications. The company collaborates with academic institutions, such as the Mathematics Department at Durham University, and maintains partnerships with healthcare organizations to validate its technology in medical imaging. Supported by venture capital and grants, IBEX Innovations continues to advance its technology to transform standard X-ray imaging into powerful diagnostic tools.

Yoyo Wallet

Series C in 2018
Yoyo Wallet is a U.K.-based mobile wallet startup that enables its users to pay for their goods with their smartphones. The company currently processes over 150,000 monthly in-store transactions by combining payment and loyalty via an easy scan. It also provides a marketing platform for retailers that enables digital customer engagement in-store. The multi-retailer mobile wallet offers loyalty programs and rewards offerings it can automatically deliver to customers based on buying patterns. Launched in 2013, Yoyo Wallet receives funding from Taavet Hinrikus and TransferWise.

Garrison

Series B in 2018
Garrison Technology Limited, established in 2014 and located in London, specializes in cybersecurity solutions tailored for enterprise needs. The company has developed an innovative anti-malware product designed to protect organizations from significant cyber threats, particularly internet-borne targeted attacks. Garrison's technology addresses critical security challenges faced by enterprises and cloud computing, effectively mitigating risks associated with malware, phishing, and other web-borne threats. This solution allows users to securely access web content, ensuring safe browsing and secure data transfer while maintaining a high-quality user experience. Garrison aims to meet the increasing demands of the enterprise cybersecurity market by providing ultra-secure internet connectivity and scalable solutions.

Oxa

Venture Round in 2018
Oxbotica develops autonomous vehicle software. They provide autonomy software that has low compute power requirements. They use laser vision and radar for localization, redundancy, and cloud management services that enable businesses to help bring autonomy to vehicles.

Genomics

Series B in 2018
Genomics plc aiming to lead the genomic transformation of healthcare, to develop and apply sophisticated analyses of massive integrated genomic and phenotypic datasets to learn about human biology and reveal the human wiring diagram They will lead the way through this challenge, using their expertise and experience to unleash the potential of genomics and set the standards by which organisations and patients can benefit from genomic data.

Dukosi

Venture Round in 2018
Dukosi Ltd specializes in the design, development, and manufacturing of battery management systems, primarily targeting the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, the company offers advanced cell sensor products for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility vehicles. Dukosi's innovative solutions enable real-time monitoring of individual battery cell performance, enhancing the health and longevity of battery systems. Their products also contribute to the efficiency of smart grids, providing reliable and renewable energy solutions for various applications, including transport networks and residential use.

Artios Pharma

Series B in 2018
Artios is an independent DNA Damage Response (DDR) company focused on developing first-in-class treatments for cancer. Established in May 2016, the Company is led by an experienced scientific and leadership team with proven expertise in DDR drug discovery. Artios is building a pipeline of next-generation DDR programs, including through a unique partnership with Cancer Research Technology (CRT), the development and commercialization arm of Cancer Research UK (CRUK), and with leading DNA repair researchers worldwide. The Company’s investors include SV Life Sciences, Merck Ventures, Imperial Innovations, Arix Bioscience PLC, CRT Pioneer Fund (managed by Sixth Element Capital), and AbbVie Ventures. Artios is based at the Babraham Institute in Cambridge, UK.

Spirea

Pre Seed Round in 2018
Spirea Ltd. operates as a healthcare technology company that has developed a smart polymer platform for the controlled delivery of drug combinations to maximise the clinical impact of medicines.

Silicon Microgravity

Venture Round in 2018
Silicon Microgravity Limited is a spin-out from Cambridge University. The underpinning sensor technology was developed through a collaboration with BP plc and provides a breakthrough in the management of oil and gas reservoirs. The technology has been developed in Cambridge University’s Nanoscience Centre primarily funded by BP and Innovate UK.

Crescendo Biologics

Series B in 2018
Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms. The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments that retain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.

Enterprise Therapeutics

Series B in 2018
Enterprise Therapeutics Ltd. is a drug discovery company based in Brighton, United Kingdom, founded in 2014. It focuses on the research and development of innovative therapies for respiratory diseases, specifically targeting chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma. The company aims to create disease-modifying therapies that address the underlying mechanisms of mucus congestion in the lungs, which can lead to breathing difficulties and increased susceptibility to lung infections. By developing these novel treatments, Enterprise Therapeutics seeks to enhance the quality of life for patients suffering from these chronic respiratory conditions.

OxSyBio

Series A in 2018
OxSyBio's vision is to ultimately produce tissues that can be used by patients in the clinic for precision medicine and organ repair or replacement. At OxSyBio, they are developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications. Their technology is based on cutting-edge research conducted by Professor Hagan Bayley’s group in the Chemistry Department at the University of Oxford. A leader in the exploration of chemical and synthetic biology his expertise cover membrane protein structure and function, single molecule chemistry and 3D printing.

Econic Technologies

Venture Round in 2018
Econic Technologies was born from a vision where catalyst chemistry is used to turn waste CO2 into positive economic and environmental potential. Incorporating waste CO2 as a feedstock for polymer preparation using our novel catalysts reduces the reliance on expensive fossil fuels, turning scientific research into business advantage for plastics manufacturers while delivering environmental gain for the benefit of all. This vision was crystallized by Professor Charlotte Williams, then at Imperial College London, and now Professor of Inorganic Chemistry in the Department of Chemistry at the University of Oxford. It was initially supported by investment from Touchstone Innovations, now IP Group plc, and Norner Verdandi, and now includes backing by Woodford Investment Management, Jetstream Capital, and OGCI Climate Investments. Much progress has been made since then. Econic’s catalyst technologies have been patented, validated in pilot operations and continue to secure additional investment. A talented team of scientists, engineers, and commercial managers now conduct their cutting-edge work in a state-of-the-art facility at Alderley Park, the internationally renowned science hub south of Manchester. All of our efforts are intently focused on the future. A future where waste CO2, a damaging greenhouse gas, is turned into a commercial and environmental gain. A future that starts now.

Ditto

Venture Round in 2018
A company at the top of its game in harnessing intelligent systems and emerging technologies. Working methodically but unobtrusively they set the gold standard in workplace automation. You can trust our proprietary and proven methodology to encapsulate your human know-how and the complex processes that characterise human decision-making.

Arkivum

Series E in 2018
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally. We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.

Akamis Bio

Venture Round in 2017
Akamis Bio is a clinical-stage oncology company whose mission is to use its groundbreaking Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to improve the lives of cancer patients. To accomplish this goal, the company is developing a portfolio of solid tumor-targeted T-SIGn® therapeutics that will allow a patient's immune system to recognize, attack, and clear their cancer.

Oxehealth

Venture Round in 2017
Oxehealth Ltd. is a technology company based in Oxford, United Kingdom, that specializes in non-contact vital signs monitoring solutions. Founded in 2012, the company has developed the Oxecam software, which enables the measurement of heart rate, respiratory rate, and blood oxygenation using a digital video camera. This innovative system is particularly beneficial in healthcare settings, including mental health facilities and care homes, where staff may not always be present to monitor patients. Oxehealth's technology provides alerts for potentially risky activities and offers objective data for care planning, enhancing the ability of clinicians and caregivers to support vulnerable individuals. By employing advanced algorithms that utilize deep learning and computer vision, Oxehealth aims to improve patient monitoring and management while allowing staff more time for direct care. The company has achieved world-first certification for its software as a medical device, marking a significant advancement in remote patient monitoring.

Navenio

Seed Round in 2017
Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

Quantum Motion

Seed Round in 2017
Quantum Motion Technologies is building a universal quantum computer in Silicon, using CMOS compatible processes.

Kudo Insurance

Venture Round in 2017
Kudo Insurance is an App that uses mobile phone telematics to assess a user’s driving and create an individual score that can then offer preferential policy discounts to good drivers. App Users are rewarded for good driving with Kudo's in-App currency Kudo Koins which they can exchange for goods, and/or entries into a cash prize draw. Kudo solution gamifies driving to created a highly interactive user experience that drives referrals and continued App usage. Driving information captured by the app could also be used as evidence in the event of a motor accident. Via unique data science, risk selection techniques and customer self-service Kudo intends to build the most profitable motor insurer. Kudo will start in the UK before expanding overseas in the next 2-3 years.

Touchstone Innovations

Acquisition in 2017
Touchstone Innovations create, build and invest in pioneering technology companies and licensing opportunities developed from outstanding scientific research focusing on the ‘Golden Triangle’ of London, Cambridge and Oxford. Their robust strategy and fully integrated business model, proven over many years, begins with original idea and extends through intellectual property (IP) protection, company formation, seed funding, incubation, scale-up and supportive investment. This provides us with a unique insight into leveraging early-stage research and turning it into substantial, high-quality, well-managed and well-funded commercial businesses. They help scientists and entrepreneurs to commercialise their idea by protecting and licensing intellectual property, leading the formation of new companies, recruiting high-calibre management teams and providing and supporting investment. They provide continuity of funding from start-up to scale-up, with initial investments from seed stage onwards. They remain an active investor throughout the lifetime of their portfolio companies, with the majority of their investment each year going into businesses they have lived with and understood for some time. This strategy substantially de-risks investment scale-up in their portfolio companies. Touchstone Innovations is at the forefront of UK early-stage technology investment. Alongside their co-investors they have leveraged over £1.5 billion to help drive high technology innovation in the UK.

Ionix Advanced Technologies

Venture Round in 2017
High temperature, high performance piezoelectric devices: reducing energy and operating costs, increasing reliability and safety Ionix Advanced Technologies specialises in high performance piezoelectric devices and materials, offering a range of sensors, actuators and transducer devices based on its novel high-temperature piezoelectric materials, with uses including NDT inspection and ultrasonic applications.

Inductosense

Series A in 2017
Inductosense is developing wireless, battery-free, sensors that can be permanently fixed to a product or structure for fast, repeatable inspections of cracks, defects or corrosion. The sensors can operate underneath coatings, insulation or repairs and can also be embedded into a material. They are entirely passive and the power and signal are provided remotely by non-contact inductive coupling from a handheld measurement probe . The technology is referred to as the Wireless And Non Destructive (WAND) system.

Zeetta

Seed Round in 2017
We are a software company that provides network automation to enable Enterprises and Service Providers to build and operate mobile private networks easily. We minimise capital and operation expenditure (CAPEX and OPEX) using configuration, assurance and adaption to orchestrate the network services consuming the network. Our cloud-native and on-premises software products use open standards coupled with patent-protected extensions for virtualisation, automation and network slicing. Zeetta Networks was spun out of the world-renowned High-Performance Networks Group of University of Bristol to commercialise the group’s originally leading network virtualisation & network slicing technology. We have an ambitious and exciting road map taking network slicing and automation to full levels of automation for users.

Eight19

Venture Round in 2017
Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route for scaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.

Zilico

Venture Round in 2017
Zilico is developing the next generation of cancer diagnostics that will provide real-time diagnosis for cervical cancer and reduce the inherent subjectivity of current methods. Two applications are under development: the first for the referral market and the second for the screening market.
Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative diagnostic technologies for acute medical settings. Founded in 2014, the company aims to enhance patient care by providing a portable, battery-powered device that enables the detection of heart-related issues, specifically acute coronary syndromes and ischemia. This technology allows for magnetocardiography to be performed directly at the patient's bedside, facilitating timely diagnosis and treatment. Creavo Medical Technologies, which has facilities in Leeds and Coventry, was established by a group of experts in clinical research and business to commercialize advancements developed by Professor Ben Varcoe from Leeds University.

Alesi Surgical

Venture Round in 2017
Alesi Surgical was founded in 2009 to develop and commercialise products that improve the safety, efficacy and outcomes of surgical procedures. The company is a spin-out from the Welsh Institute for Minimal Access Therapy (WIMAT), a leading surgical training centre in the UK. Alesi Surgical has a unique level of access to experienced surgeons, surgical trainers and trainees, which allows it to identify issues in procedures and design devices to address these issues.

Ultraleap

Series B in 2017
Ultraleap is the world leader in mid-air haptics and 3D hand tracking. The company's breakthrough haptic technology (previously Ultrahaptics) uses ultrasound to create rich, three-dimensional shapes and textures that can be felt, but not seen.

Saw DX

Venture Round in 2017
SAW DX Ltd is a technology development company based in Glasgow, United Kingdom, that specializes in designing and manufacturing point-of-care (POC) diagnostic devices. Founded in 2013, the company focuses on leveraging Acoustic-Flow technology, which utilizes surface acoustic waves to facilitate diagnostic tests. This innovative approach allows for the manipulation of patient samples on disposable chips, enabling fluid movement, mixing, and the release of DNA without the need for preprocessing. SAW DX's product portfolio includes prototypes for diagnosing sexually transmitted infections, a reader and cartridge system for tuberculosis assays, and a platform for parasite enrichment and molecular detection. By providing advanced diagnostic solutions, SAW DX aims to support life sciences and diagnostics companies in improving their product offerings and enhancing the efficiency of infectious disease diagnosis.

Refract

Seed Round in 2017
Every conversation, call, demo, meeting and email contains a treasure trove of insight. The words used, phrases chosen, questions asked all impact on success. Yet, throughout our own careers, sales coaching always felt broken. We would ride along calls and demos, share ideas and feedback, all without a shared reflective view. And as powerful as coaching continually proves to be, it only accounts for less than 5% of sales managers time. So,to make sales coaching simple, more time efficient and to amplify the benefits, we built Refract. By highlighting the decisive and defining moments of these conversations and surfacing coachable insight specific to your business and reps, mistakes and missed opportunities can be remedied. Great moments can be shared amongst the team. The best made available in a searchable library. Our AI technology delivers personalized insight, based on your business and your reps, showing the actions and words that align with top performers and results. We work with a range of global clients, with teams from just a handful to the 1000’s. And whilst every organization is different, they all have one thing in common. They’re passionate about improving sales conversations, and that’s just what we’re here for.

Dukosi

Series A in 2017
Dukosi Ltd specializes in the design, development, and manufacturing of battery management systems, primarily targeting the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, the company offers advanced cell sensor products for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility vehicles. Dukosi's innovative solutions enable real-time monitoring of individual battery cell performance, enhancing the health and longevity of battery systems. Their products also contribute to the efficiency of smart grids, providing reliable and renewable energy solutions for various applications, including transport networks and residential use.

Microbiotica

Seed Round in 2016
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and in vivo models.

Parkwalk Advisors

Acquisition in 2016
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009, anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth. Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Oxford Nanopore Technologies

Venture Round in 2016
Oxford Nanopore Technologies is a biotechnology company that develops and commercializes nanopore sequencing technology. Their novel, electronics-based DNA/RNA sequencing technology is being used in more than 80 countries, for a range of biological research applications. These include large scale human genomics, cancer research, microbiology, plant science, and environmental research. Nanopore sequencing is also being explored beyond research, where it has the potential to provide rapid, meaningful information in the fields of healthcare, agriculture, food and water surveillance, and education. Oxford Nanopore’s proprietary technology is fully scalable for any requirement. Small formats such as Flongle address the need for on-demand, rapid, smaller tests or experiments, and can be used in labs or in the field. The pocket-sized MinION is a powerful and portable sequencing device that can deliver high volumes of long-read sequence data. The benchtop GridION X5 can run up to five MinION Flow Cells at a time, on-demand, for larger genomics projects. The recently launched PromethION is the largest format for nanopore sequencing, designed to offer on-demand use of up to 48 Flow Cells – each of which can offer more than 100Gb of sequencing data. Focusing on ease of use, nanopore sequencing offers easy and rapid preparation, including a ten-minute library preparation kit and the automated, programmable VolTRAX. Supported by a broad patent portfolio, the Oxford Nanopore pipeline includes multiple generations of nanopore-based sensing technologies, including those based on both biological and solid-state nanopores.

AccelerComm

Seed Round in 2016
AccelerComm is an exciting semiconductor IP-core company that provides solutions to accelerate the next generations of wireless communications (3GPP rel 14, rel 15 and beyond). Their technology solves the bottleneck that would otherwise limit the speed of next generation wireless communication, namely the error correction decoding that is required to overcome the effects of noise, interference and poor signal strength.

Arkivum

Series D in 2016
Arkivum delivers software, services and domain expertise for long term data management and digital preservation globally. We serve organisations around the world in data intensive and regulated markets. We make your long term data secure, accessible and usable for as long as you need it, providing assurance your data is where you need it, when you need it. Our domain expertise means we can guarantee 100% data integrity and best practice guidance for dealing with new compliance requirements as they are introduced. Our vendor neutral technology and no data lock-in means your data lives where you want it to and you own your data at all times. Arkivum delivers complete confidence in preserving, meeting complex compliance and regulatory requirements and creating business value from your data. Bringing your archived data to life.

Cambridge Innovation Capital

Venture Round in 2016
Cambridge Innovation Capital backs life sciences and technology companies with an affiliation to Cambridge, Europe’s capital for innovation. As a preferred investor for the University of Cambridge, they have unparalleled access to investment opportunities in the ecosystem. Since our inception in 2013, they have raised £275 million to invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, the internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health, and genomics/proteomics.

Uniphy

Seed Round in 2016
Uniphy is a technology company specializing in the development of innovative optical and hybrid touchscreen solutions. The company focuses on creating free-form touchscreen interfaces that enhance systems automation by offering precise touch detection and integrating mechanical dials and control knobs. Uniphy's technology utilizes a unique light-scattering dopant, allowing original equipment manufacturers to design versatile smart surfaces with extensive human-machine interface capabilities. The company's commitment to continuous innovation in hardware, software, and materials engineering results in products that are not only aesthetically pleasing and robust but also environmentally sustainable and cost-effective. Uniphy's patented approach to smart surfaces distinguishes it from competitors and addresses the limitations of both established and emerging technologies in the touchscreen market.

8Power

Seed Round in 2016
8Power Limited specializes in the manufacturing of autonomous sensor systems tailored for various sectors, including automotive, transportation, civil engineering, industrial equipment, and utility infrastructure. The company has developed wireless sensor technology that provides real-time condition monitoring data and analytics for industrial applications. This technology enables clients to monitor the performance of their assets, such as pumps, motors, and gearboxes, across numerous remote locations. By offering a cost-effective solution, 8Power facilitates easy installation and effective machine condition monitoring, serving industries such as water and waste treatment, manufacturing, and oil and gas.

Mirriad

Series D in 2016
Mirriad’s award-winning solution unleashes new revenue for content producers and distributors by creating new advertising inventory in content. Our patented, AI and computer vision technology dynamically inserts products and innovative signage formats after content is produced. Mirriad’s market-first solution seamlessly integrates with existing subscription and advertising models, and dramatically improves the viewer experience by limiting commercial interruptions. Mirriad currently operates in the US, Europe and China.

Stratium

Seed Round in 2016
Stratium® is a manufacturer of quantum cascade lasers (QCLs). We are committed to addressing emerging OEM gas-sensing markets by introducing the next generation of advanced QCLs, with industrial-grade performance and reliability.

Zeetta

Seed Round in 2016
We are a software company that provides network automation to enable Enterprises and Service Providers to build and operate mobile private networks easily. We minimise capital and operation expenditure (CAPEX and OPEX) using configuration, assurance and adaption to orchestrate the network services consuming the network. Our cloud-native and on-premises software products use open standards coupled with patent-protected extensions for virtualisation, automation and network slicing. Zeetta Networks was spun out of the world-renowned High-Performance Networks Group of University of Bristol to commercialise the group’s originally leading network virtualisation & network slicing technology. We have an ambitious and exciting road map taking network slicing and automation to full levels of automation for users.

Mixergy

Seed Round in 2016
Mixergy Ltd. offer a cost-effective solution to save energy and facilitate more renewable power generation through grid balancing. Mixergy tanks achieve better utilisation of solar PV and heat pumps.

Navenio

Seed Round in 2016
Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons or wi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice. The company was founded in 2015 and is headquartered in Oxford, England.

Ultraleap

Series A in 2015
Ultraleap is the world leader in mid-air haptics and 3D hand tracking. The company's breakthrough haptic technology (previously Ultrahaptics) uses ultrasound to create rich, three-dimensional shapes and textures that can be felt, but not seen.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.